Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1996 Apr;223(4):384–394. doi: 10.1097/00000658-199604000-00007

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

C H Su 1, S H Tsay 1, C C Wu 1, Y M Shyr 1, K L King 1, C H Lee 1, W Y Lui 1, T J Liu 1, F K P'eng 1
PMCID: PMC1235134  PMID: 8633917

Abstract

OBJECTIVE; Morbidity and mortality involved in the resection of hilar cholangiocarcinoma were reviewed retrospectively. The clinicopathologic and laboratory parameters that might influence the patient's survival also were re-evaluated. SUMMARY BACKGROUND DATA: Although much progress has been made in the diagnosis and management of hilar cholangiocarcinoma, long-term outlook for most patients remains poor. Surgical resection is usually prohibited because of its local invasiveness, and most patients can only be managed by palliative drainage. Recently, many surgeons have adopted a more aggressive resection with varying degrees of success. Several prognostic factors in bile duct carcinoma have been proposed; however, no reports have specifically focused on resected hilar cholangiocarcinoma and its prognostic survival factors using multivariate analysis. METHODS: The clinical records and pathologic slides of 49 cases with resected hilar cholangiocarcinoma were reviewed retrospectively. Twenty clinical and laboratory parameters were evaluated for their correlation with postoperative morbidity and mortality, whereas 31 variables were evaluated for their significance with postoperative survival. Variables showing statistical significance in the first univariate analysis were included in the following multivariate analysis using stepwise logistic regression test for factors affecting morbidity and mortality and Cox stepwise proportional hazard model for factors influencing survival. RESULTS: There were 5 in-hospital deaths, and the cumulative 5-year survival rate in 44 patients who survived was 14.9%, with a median survival of 14.0 months. Multivariate analysis disclosed that co-existent hepatolithiasis and lower serum asparate aminotransferase levels (<90 U/L) had a significant low incidence of postoperative morbidity, whereas a serum albumin of less than 3 g/dL was the only significant factor affecting mortality. Regarding survival, univariate analysis identified eight significant factors: 1) total bilirubin > or = 10 mg/dL, 2) curative resection, 3) histologic type, 4) perineural invasion, 5) liver invasion, 6) depth of cancer invasion, 7) positive proximal resected margin, and 8) positive surgical margin. However, multivariate analysis disclosed total bilirubin > or = 10 mg/dL, curative resection, and histologic type as the three most significant independent variables. CONCLUSIONS: Surgical resection provides the best survival for hilar cholangiocarcinoma. An adequate nutritional support to increase serum albumin over 3 g/dL is the most important factor to decrease postoperative mortality. Moreover, preoperative biliary drainage to decrease jaundice and a curative resection with adequate surgical margin are recommended if longer survival is anticipated. Patients with well-differentiated adenocarcinoma seem to survive longer compared to those with moderately or poorly differentiated tumors.

Full text

PDF
384

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adkins R. B., Jr, Dunbar L. L., McKnight W. G., Farringer J. L., Jr An aggressive surgical approach to bile duct cancer. Am Surg. 1986 Mar;52(3):134–139. [PubMed] [Google Scholar]
  2. Akwari O. E., Kelly K. A. Surgical treatment of adenocarcinoma. Location: junction of the right, left, and common hepatic biliary ducts. Arch Surg. 1979 Jan;114(1):22–25. doi: 10.1001/archsurg.1979.01370250024004. [DOI] [PubMed] [Google Scholar]
  3. Beazley R. M., Hadjis N., Benjamin I. S., Blumgart L. H. Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments. Ann Surg. 1984 Jun;199(6):623–636. doi: 10.1097/00000658-198406000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bhuiya M. R., Nimura Y., Kamiya J., Kondo S., Fukata S., Hayakawa N., Shionoya S. Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg. 1992 Apr;215(4):344–349. doi: 10.1097/00000658-199204000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bhuiya M. R., Nimura Y., Kamiya J., Kondo S., Nagino M., Hayakawa N. Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg. 1993 Sep-Oct;17(5):653–657. doi: 10.1007/BF01659134. [DOI] [PubMed] [Google Scholar]
  6. Bismuth H., Nakache R., Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg. 1992 Jan;215(1):31–38. doi: 10.1097/00000658-199201000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Blamey S. L., Fearon K. C., Gilmour W. H., Osborne D. H., Carter D. C. Prediction of risk in biliary surgery. Br J Surg. 1983 Sep;70(9):535–538. doi: 10.1002/bjs.1800700910. [DOI] [PubMed] [Google Scholar]
  8. Braasch J. W., Gray B. N. Considerations that lower pancreatoduodenectomy mortality. Am J Surg. 1977 Apr;133(4):480–484. doi: 10.1016/0002-9610(77)90135-0. [DOI] [PubMed] [Google Scholar]
  9. Cameron J. L., Pitt H. A., Zinner M. J., Kaufman S. L., Coleman J. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg. 1990 Jan;159(1):91–98. doi: 10.1016/s0002-9610(05)80612-9. [DOI] [PubMed] [Google Scholar]
  10. Dixon J. M., Armstrong C. P., Duffy S. W., Davies G. C. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut. 1983 Sep;24(9):845–852. doi: 10.1136/gut.24.9.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Evander A., Fredlund P., Hoevels J., Ihse I., Bengmark S. Evaluation of aggressive surgery for carcinoma of the extrahepatic bile ducts. Ann Surg. 1980 Jan;191(1):23–29. doi: 10.1097/00000658-198001000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hatfield A. R., Tobias R., Terblanche J., Girdwood A. H., Fataar S., Harries-Jones R., Kernoff L., Marks I. N. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet. 1982 Oct 23;2(8304):896–899. doi: 10.1016/s0140-6736(82)90866-2. [DOI] [PubMed] [Google Scholar]
  13. Hayes J. K., Jr, Sapozink M. D., Miller F. J. Definitive radiation therapy in bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1988 Sep;15(3):735–744. doi: 10.1016/0360-3016(88)90319-7. [DOI] [PubMed] [Google Scholar]
  14. Ide H., Nakamura T., Hayashi K., Endo T., Kobayashi A., Eguchi R., Hanyu F. Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg. 1994 May-Jun;18(3):321–330. doi: 10.1007/BF00316810. [DOI] [PubMed] [Google Scholar]
  15. Ishikawa O., Ohhigashi H., Sasaki Y., Kabuto T., Fukuda I., Furukawa H., Imaoka S., Iwanaga T. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg. 1988 Aug;208(2):215–220. doi: 10.1097/00000658-198808000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. KLATSKIN G. ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. Am J Med. 1965 Feb;38:241–256. doi: 10.1016/0002-9343(65)90178-6. [DOI] [PubMed] [Google Scholar]
  17. Launois B., Campion J. P., Brissot P., Gosselin M. Carcinoma of the hepatic hilus. Surgical management and the case for resection. Ann Surg. 1979 Aug;190(2):151–157. doi: 10.1097/00000658-197908000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lygidakis N. J., van der Heyde M. N., van Dongen R. J., Kromhout J. G., Tytgat G. N., Huibregtse K. Surgical approaches for unresectable primary carcinoma of the hepatic hilus. Surg Gynecol Obstet. 1988 Feb;166(2):107–114. [PubMed] [Google Scholar]
  19. Makuuchi M., Thai B. L., Takayasu K., Takayama T., Kosuge T., Gunvén P., Yamazaki S., Hasegawa H., Ozaki H. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990 May;107(5):521–527. [PubMed] [Google Scholar]
  20. McPherson G. A., Benjamin I. S., Hodgson H. J., Bowley N. B., Allison D. J., Blumgart L. H. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg. 1984 May;71(5):371–375. doi: 10.1002/bjs.1800710522. [DOI] [PubMed] [Google Scholar]
  21. Mizumoto R., Kawarada Y., Suzuki H. Surgical treatment of hilar carcinoma of the bile duct. Surg Gynecol Obstet. 1986 Feb;162(2):153–158. [PubMed] [Google Scholar]
  22. Mizumoto R., Ogura Y., Kusuda T. Definition and diagnosis of early cancer of the biliary tract. Hepatogastroenterology. 1993 Feb;40(1):69–77. [PubMed] [Google Scholar]
  23. Myburgh J. A. Resection and bypass for malignant obstruction of the bile duct. World J Surg. 1995 Jan-Feb;19(1):108–112. doi: 10.1007/BF00316991. [DOI] [PubMed] [Google Scholar]
  24. Nagorney D. M., McPherson G. A. Carcinoma of the gallbladder and extrahepatic bile ducts. Semin Oncol. 1988 Apr;15(2):106–115. [PubMed] [Google Scholar]
  25. Nakayama T., Ikeda A., Okuda K. Percutaneous transhepatic drainage of the biliary tract: technique and results in 104 cases. Gastroenterology. 1978 Mar;74(3):554–559. [PubMed] [Google Scholar]
  26. Nimura Y., Hayakawa N., Kamiya J., Kondo S., Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990 Jul-Aug;14(4):535–544. doi: 10.1007/BF01658686. [DOI] [PubMed] [Google Scholar]
  27. Nimura Y., Hayakawa N., Kamiya J., Maeda S., Kondo S., Yasui A., Shionoya S. Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg. 1991 Jun;78(6):727–731. doi: 10.1002/bjs.1800780629. [DOI] [PubMed] [Google Scholar]
  28. Nimura Y., Hayakawa N., Kamiya J., Maeda S., Kondo S., Yasui A., Shionoya S. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology. 1991 Apr;38(2):170–175. [PubMed] [Google Scholar]
  29. Oberfield R. A., Rossi R. L. The role of chemotherapy in the treatment of bile duct cancer. World J Surg. 1988 Feb;12(1):105–108. doi: 10.1007/BF01658494. [DOI] [PubMed] [Google Scholar]
  30. Ogura Y., Mizumoto R., Isaji S., Kusuda T., Matsuda S., Tabata M. Radical operations for carcinoma of the gallbladder: present status in Japan. World J Surg. 1991 May-Jun;15(3):337–343. doi: 10.1007/BF01658725. [DOI] [PubMed] [Google Scholar]
  31. Okuda K., Kubo Y., Okazaki N., Arishima T., Hashimoto M. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer. 1977 Jan;39(1):232–246. doi: 10.1002/1097-0142(197701)39:1<232::aid-cncr2820390137>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  32. Pichlmayr R., Ringe B., Lauchart W., Bechstein W. O., Gubernatis G., Wagner E. Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg. 1988 Feb;12(1):68–77. doi: 10.1007/BF01658489. [DOI] [PubMed] [Google Scholar]
  33. Pitt H. A., Cameron J. L., Postier R. G., Gadacz T. R. Factors affecting mortality in biliary tract surgery. Am J Surg. 1981 Jan;141(1):66–72. doi: 10.1016/0002-9610(81)90014-3. [DOI] [PubMed] [Google Scholar]
  34. Pitt H. A., Gomes A. S., Lois J. F., Mann L. L., Deutsch L. S., Longmire W. P., Jr Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg. 1985 May;201(5):545–553. doi: 10.1097/00000658-198505000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Praderi R. C. Twelve years' experience with transhepatic intubation. Ann Surg. 1974 Jun;179(6):937–940. doi: 10.1097/00000658-197406000-00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ragins H., Diamond A., Meng C. H. Intrahepatic cholangiojejunostomy in the management of malignant biliary obstruction. Surg Gynecol Obstet. 1973 Jan;136(1):27–32. [PubMed] [Google Scholar]
  37. Su C. H., P'eng F. K., Lui W. Y. Factors affecting morbidity and mortality in biliary tract surgery. World J Surg. 1992 May-Jun;16(3):536–540. doi: 10.1007/BF02104465. [DOI] [PubMed] [Google Scholar]
  38. Sullivan R. C., Faris T. D. Hepaticojejunostomy. Modified longmire operation for bile duct carcinoma. Am J Surg. 1967 Nov;114(5):722–725. doi: 10.1016/0002-9610(67)90136-5. [DOI] [PubMed] [Google Scholar]
  39. Terblanche J., Saunders S. J., Louw J. H. Prolonged palliation in carcinoma of the man hepatic duct junction. Surgery. 1972 May;71(5):720–731. [PubMed] [Google Scholar]
  40. Tompkins R. K., Thomas D., Wile A., Longmire W. P., Jr Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg. 1981 Oct;194(4):447–457. doi: 10.1097/00000658-198110000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wang Y. J., Lee S. D., Shyu J. K., Lo K. J. Clinical experience in 126 patients with tissue-proved proximal cholangiocarcinoma. J Gastroenterol Hepatol. 1994 Mar-Apr;9(2):134–137. doi: 10.1111/j.1440-1746.1994.tb01232.x. [DOI] [PubMed] [Google Scholar]
  42. White T. T. Skeletization resection and central hepatic resection in the treatment of bile duct cancer. World J Surg. 1988 Feb;12(1):48–51. doi: 10.1007/BF01658485. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES